Trials / Not Yet Recruiting
Not Yet RecruitingNCT06683534
Palmitic Acid and Human Microvascular Function
Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Medical College of Wisconsin · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to learn how a supplement Quercetin can affect microvascular function. Participants will: * give two blood draws of 5 mL each * have a camera placed under the tongue to take pictures of blood vessels * have 2 laser Doppler microdialysis catheters placed on the forearm to monitor blood vessels before and after local drug infusion Researchers will compare blood vessel function of those who take estrogen supplements to those who do not.
Conditions
- Microvascular Dysfunction
- Microvasculature
- Cardiovascular Diseases
- Cardiovascular Diseases (CVD)
- Microvascular Health
- Obesity and Overweight
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Quercetin (dietary supplement) | Quercetin will be provided to take one Quercetin per day for 30 days to look for differences in microvascular function. |
| DRUG | Placebo | Subjects randomized to receive placebo will be administered a standard placebo sugar pill. |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2030-12-01
- Completion
- 2030-12-01
- First posted
- 2024-11-12
- Last updated
- 2026-01-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06683534. Inclusion in this directory is not an endorsement.